Insmed (INSM) Current Deferred Revenue (2010 - 2014)
Insmed (INSM) posted quarterly Current Deferred Revenue of $423000.0 for Q4 2014, up 227.91% year-over-year from $129000.0 in Q4 2013, and up 31.78% quarter-over-quarter from $321000.0 in Q3 2014.
Insmed (INSM) Current Deferred Revenue (2010 - 2014) Analysis & Trends
Insmed's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $423000.0 for Q4 2014.
- In Q4 2014, Current Deferred Revenue rose 227.91% year-over-year to $423000.0; the TTM figure through Dec 2014 stood at $423000.0 (up 227.91% YoY), while the FY2014 annual figure was $423000.0, up 227.91% from the prior year.
- Current Deferred Revenue for Q4 2014 stood at $423000.0, up from $321000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $423000.0 in Q4 2014, with the low at $121000.0 in Q1 2014.
- The 5-year median for Current Deferred Revenue is $150500.0 (2010), against an average of $191312.5.
- The sharpest annual moves came in 2012 and 2014: Current Deferred Revenue slumped 64.13% in 2012, then jumped 227.91% in 2014.
- Insmed's Current Deferred Revenue stood at $150000.0 in 2010, then advanced by 4.0% to $156000.0 in 2011, then retreated by 4.49% to $149000.0 in 2012, then decreased by 13.42% to $129000.0 in 2013, then surged by 227.91% to $423000.0 in 2014.
- Business Quant data shows INSM's Current Deferred Revenue at $423000.0 in Q4 2014, $321000.0 in Q3 2014, and $167000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 423,000.00 |
| Sep 30, 2014 | 321,000.00 |
| Jun 30, 2014 | 167,000.00 |
| Mar 31, 2014 | 121,000.00 |
| Dec 31, 2013 | 129,000.00 |
| Sep 30, 2013 | 134,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 144,000.00 |
| Dec 31, 2012 | 149,000.00 |
| Sep 30, 2012 | 151,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 154,000.00 |
| Dec 31, 2011 | 156,000.00 |
| Sep 30, 2011 | 421,000.00 |
| Jun 30, 2011 | 150,000.00 |
| Dec 31, 2010 | 150,000.00 |